These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 95247)

  • 21. Clinical pharmacokinetics of N-acetylprocainamide.
    Connolly SJ; Kates RE
    Clin Pharmacokinet; 1982; 7(3):206-20. PubMed ID: 6178545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procainamide: clinical pharmacology and efficacy against ventricular arrhythmias.
    Giardina EG
    Ann N Y Acad Sci; 1984; 432():177-88. PubMed ID: 6084435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of desethyl procainamide in patients: a new metabolite of procainamide.
    Ruo TI; Morita Y; Atkinson AJ; Henthorn T; Thenot JP
    J Pharmacol Exp Ther; 1981 Feb; 216(2):357-62. PubMed ID: 6162026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of antiarrhythmic effects of procainamide, N-acetylprocainamide, and p-hydroxy-N-(3-diethylaminopropyl)benzamide.
    Reynolds RD; Burmeister WE; Calzadilla SV; Lee RJ; Reidenberg MM; Drayer DE
    Proc Soc Exp Biol Med; 1982 Feb; 169(2):156-60. PubMed ID: 6174988
    [No Abstract]   [Full Text] [Related]  

  • 25. Acecainide for ventricular arrhythmias.
    Vyden JK
    JAMA; 1982 Feb; 247(5):581. PubMed ID: 6172606
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative studies of the hemodynamic effects of procainamide and N-acetylprocainamide in rabbits].
    Matusewicz W
    Kardiol Pol; 1984; 27(5):393-400. PubMed ID: 6208404
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemodynamic effects of N-acetylprocainamide in man: comparison with other antiarrhythmic drugs.
    Josephson MA; Singh BN
    Angiology; 1986 Dec; 37(12 Pt 2):950-8. PubMed ID: 2433969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of procainamide and N-acetylprocainamide in rats.
    Kamath BL; Lai CM; Gupta SD; Durrani MJ; Yacobi A
    J Pharm Sci; 1981 Mar; 70(3):299-302. PubMed ID: 6167709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics and preliminary evaluation of the anti-arrhythmic effectiveness of N-acetylprocainamide in ventricular disorders of cardiac rhythm].
    Ochotny R; Lowicki Z
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1445-7. PubMed ID: 2421273
    [No Abstract]   [Full Text] [Related]  

  • 30. Simultaneous determination of procainamide and N-acetylprocainamide in serum by gas chromatography with nitrogen-selective detection.
    Yamaji A; Kataoka K; Oishi M; Kanamori N; Hiraoka E; Mishima M
    J Chromatogr; 1987 Mar; 415(1):143-7. PubMed ID: 2438294
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetics of procainamide N-acetylation in the rat in vivo and in the perfused rat liver preparation.
    Pang KS; Huang JC; Finkle C; Kong P; Cherry WF; Fayz S
    Drug Metab Dispos; 1984; 12(3):314-22. PubMed ID: 6203693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
    Jung D; Nanavaty M; Prasad P
    Drug Metab Dispos; 1985; 13(3):359-63. PubMed ID: 2410212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide.
    Winkle RA; Jaillon P; Kates RE; Peters F
    Am J Cardiol; 1981 Jan; 47(1):123-30. PubMed ID: 6161534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resin hemoperfusion for severe N-acetylprocainamide toxicity in patients with renal failure.
    Raja R; Kramer M; Alvis R; Goldstein S; DeLosAngeles A
    Trans Am Soc Artif Intern Organs; 1984; 30():18-20. PubMed ID: 6085435
    [No Abstract]   [Full Text] [Related]  

  • 35. N-acetylprocainamide induced changes in refractoriness and monophasic action potentials of the dog heart in situ.
    Amlie JP; Landmark K
    Cardiovasc Res; 1981 Mar; 15(3):159-63. PubMed ID: 6167356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clearance of procainamide and N-acetylprocainamide in patients undergoing continuous ambulatory peritoneal dialysis.
    Raehl CL; Moorthy AV; Beirne GJ; Pitterle ME
    Clin Pharm; 1985; 4(6):669-72. PubMed ID: 2416503
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of evoked endocardial response for assessment of antiarrhythmic drug effects on myocardium.
    Furukawa T; Taniguchi K; Takeuchi J
    Bull Tokyo Med Dent Univ; 1988 Sep; 35(3):33-44. PubMed ID: 2466578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aging and renal clearance of procainamide and acetylprocainamide.
    Reidenberg MM; Camacho M; Kluger J; Drayer DE
    Clin Pharmacol Ther; 1980 Dec; 28(6):732-5. PubMed ID: 6160015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian changes in procainamide and N-acetylprocainamide kinetics in the rat.
    Bruguerolle B; Jadot G
    J Pharm Pharmacol; 1985 Sep; 37(9):654-6. PubMed ID: 2416904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations of desethyl N-acetylprocainamide in patients treated with procainamide and N-acetylprocainamide.
    Ruo TI; Thenot JP; Stec GP; Atkinson AJ
    Ther Drug Monit; 1981; 3(3):231-7. PubMed ID: 6172888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.